COVID-19 vaccine: Serum Institute gets DCGI’s nod to manufacture Sputnik V vaccine in India

Serum Institute of India has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Russia for developing the Sputnik V vaccine at its licensed Hadapsar facility.

from Jagran Josh https://ift.tt/34SHWzE